2,544
Views
3
CrossRef citations to date
0
Altmetric
Articles

Impact of Omega-3 Fatty Acids Among Other Nonpharmacological Interventions on Behavior and Quality of Life in Children with Compromised Conduct in Spain

, PhD, MD, , PhD, MD, , MSc, PhD & , MSc, MD

References

  • American Academy of Pediatrics (AAP). 2000. Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 105:1158–1170.
  • American Psychiatric Association (APA). 1995. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington (DC): American Psychiatric Association.
  • Bloch MH, Qawasmi A. 2011. Omega-3 fatty acid supplementation for the treatment of children with attention-Deficiency/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 50(10):991–1000.
  • Cortese S, Brown TE, Corkum P, Gruber R, O'Brien LM, Stein M, Weiss M, Owens J. 2013. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 52(8):784–796.
  • Costello EJ, Costello AJ, Edelbrock C, Burns BJ, Dulcan MK, Brent D, Janiszewski S. 1988. Psychiatric disorders in pediatric primary care. Arch Gen Psychiatry. 45(12):1107–1016.
  • Curtis LT, Patel K. 2008. Nutritional and environmental approaches to preventing and treating autism and Attention Deficiency hyperactivity disorder (ADHD): a review. J Altern Complement Med. 14(1):79–85.
  • Fajardo F, León B, Felipe E, Ribeiro EJ. 2012. Mental health in the age group 4–15 years based on the results of the national survey of health 2006, Spain. Rev Esp Salud Publica. 86(4):445–451.
  • Fonseca-Pedrero E, Paino M, Lemos-Giráldez S, Muñiz J. 2011. Prevalence of emotional and behavioral symptoms in Spanish adolescents using the Strengths and Difficulties Questionnaire (SDQ). RPPC. 16(1):17–25.
  • Foster J. 2010. El niño con problemas de conducta y/o aprendizaje escolar. Boletín Especial Sociedad de Psiquiatría y Neurología de la Infancia y Adolescencia. [accessed 2016 July 25]. http://escuela.med.puc.cl/paginas/publicaciones/manualped/probcond.html.
  • Gillies D, Sinn JKH, Lad SS, Leach MJ, Ross MJ. 2012. Polyunsaturated fatty acids (PUFA) for attention Deficiency hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 11(7):CD007986.
  • Goodman R. 1997. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 38(5):581–586.
  • Gutman LM, Vorhaus J. 2012. The impact of pupil behaviour and wellbeing on educational outcomes. London (UK): Childhood Wellbeing Research Centre, Institute of Education, University of London..
  • Huss M, Völp A, Stauss-Grabo M. 2010. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-Deficiency/hyperactivity problems - an observational cohort study. Lipids Health Dis. 9(1):105.
  • Kazdin AE. 1997. Practitioner review: psychosocial treatments for conduct disorder in children. J Child Psychol Psychial. 38(2):161–178.
  • Kidd PM. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 12(3):207–227.
  • Kirov R, Brand S. 2014. Sleep problems and their effect in ADHD. Expert Rev Neurother. 14(3):287–299.
  • National Council for Special Education (NCSE). 2012. The Education of Students with Challenging Behaviour arising from Severe Emotional Disturbance/Behavioural Disorders. NCSE Policy Advice n° 3.
  • National Institute of Statistics (Spain) 2011. National Health Survey. [accessed 2016 July 25]. http://www.ine.es/inebmenu/mnu_salud.htm.
  • Raine A, Portnoy J, Liu J, Mahoomed T, Hibbeln JR. 2015. Reduction in behavior problems with omega-3 supplementation in children aged 8-16 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial. J Child Psychol Psychiatr. 56(5):509–520.
  • Richardson AJ, Montgomery P. 2005. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 115(5):1360–1366.
  • Richardson AJ. 2006. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry. 18(2):155–172.
  • Service Children’s Education (SCE). 2015. Guidance – Managing Challenging Behaviour. [accessed 2016 July 25]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/339074/Managing_Challenging_Behaviour_Final-U.pdf.
  • Sonuga-Barke EJS, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, European ADHD Guidelines Group, et al. 2013. Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments. Am J Psychiatry. 170(3):275–289.
  • Um YH, Hong SC, Jeong JH. 2017. Sleep problems as predictors in attention-deficit hyperactivity disorder: causal mechanisms, consequences and treatment. Clin Psychopharmacol Neurosci. 15(1):9–18.